EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RAGE and its ligands in breast cancer progression and metastasis

Madalina Coser, Bogdan Mihai Neamtu, Bogdan Pop, Calin Remus Cipaian, Maria Crisan

Oncology Reviews · 03.01.2025 · 18

DOI: 10.3389/or.2024.1507942 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reviews, online erschienen am 03.01.2025. Verfasst von Madalina Coser und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology, Doctoral School "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Breast cancer is the most common form of cancer diagnosed worldwide and the leading cause of death in women globally, according to Globocan 2020. Hence, investigating novel pathways implicated in cancer progression and metastasis could lead to the development of targeted therapies and new treatment strategies in breast cancer. Recent studies reported an interplay between the receptor for advanced glycation end products (RAGE) and its ligands, S100 protein group, advanced glycation end products (AGEs) and high-mobility group box 1 protein (HMGB1) and breast cancer growth and metastasis. Materials and methods We used articles available in the NCBI website database PubMed to write this scoping review. The search words used were ‘RAGE receptor’ AND/OR ‘breast cancer, RAGE ligands, glycation end products’. A total of 90 articles were included. We conducted a meta-analysis to assess the relationship between the RAGE rs1800624 polymorphism and breast cancer risk using fixed-effect or random-effect models to calculate odds ratios (ORs) and their corresponding 95% confidence intervals (95% CIs).

Results

RAGE upon activation by its ligands enhances downstream signaling pathways, contributing to breast cancer cells migration, growth, angiogenesis, metastasis, and drug resistance. In addition, studies have shown that RAGE and its ligands influence the way breast cancer cells interact with immune cells present in the tumor microenvironment (macrophages, fibroblasts), thus regulating it to promote tumor growth and metastasis.

Conclusion

Breast cancers with a high expression of RAGE are associated with poor prognosis. Targeting RAGE and its ligands impairs cell invasion and metastasis, showing promising potential for further research as potential prognostic biomarkers or targeted onco-therapeutics.

Schlagwörter

Stichwörter der Autor:innen

AGEsHMGB1RAGES100breast cancerlifestylemetastasis

Autor:innen und Institutionen

  • Department of Histology, Doctoral School "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania.
  • Clinical Medical Department, Center for Research in Mathematics and Applications, Faculty of Medicine, "Lucian Blaga" University Sibiu, Sibiu, Romania.
  • Department of Clinical Research, Pediatric Clinical Hospital Sibiu, Sibiu, Romania.
  • Department of Pathology, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania.
  • Department of Pathology, "Prof. Dr. ion Chiricuta" Institute of Oncology Cluj-Napoca, Cluj-Napoca, Romania.
  • Second Medical Clinic, Sibiu County Clinical Emergency Hospital, Sibiu, Romania.

Zitieren

APA

Coser, M., Neamtu, B. M., Pop, B., Cipaian, C. R., & Crisan, M. (2025). RAGE and its ligands in breast cancer progression and metastasis. Oncology Reviews, 18. https://doi.org/10.3389/or.2024.1507942

Vancouver

Coser M, Neamtu BM, Pop B, Cipaian CR, Crisan M. RAGE and its ligands in breast cancer progression and metastasis. Oncology Reviews. 2025;18. doi:10.3389/or.2024.1507942

BibTeX
@article{Coser2025,
  author = {Coser, Madalina and Neamtu, Bogdan Mihai and Pop, Bogdan and Cipaian, Calin Remus and Crisan, Maria},
  title = {RAGE and its ligands in breast cancer progression and metastasis},
  journal = {Oncology Reviews},
  year = {2025},
  volume = {18},
  doi = {10.3389/or.2024.1507942}
}
Kostenlos starten →